Biotechnology Headlines from PR Newswire

< Go Back

Vanda Pharmaceuticals to Announce First Quarter 2014 Financial Results on May 8, 2014
iCo Therapeutics Announces Year End 2013 Financial Results English
Dyadic Announces Launch of Fibrezyme® G4
Oramed Pharmaceuticals Presents Data from Phase IIa Trial with ORMD-0801 in Type 2 Diabetes at the 2014 Diabetes Summit
At Six Month Post-Launch, Nearly One Half of Surveyed U.S. Oncologists Have Prescribed Boehringer Ingelheim's Gilotrif for Non-Small-Cell Lung Cancer
Protein Expression Market worth $1,396.68 Million by 2018
Z Trim To Present At The Florida School Nutrition Association Annual Conference
Contract Research Organization, WCCT Global, Announces Attendance at the 2014 American Society of Cataract and Refractive Surgery Conference
Greater Reductions in Exacerbations Remains an Open Area of Opportunity in the Chronic Obstructive Pulmonary Disease Market
BD Launches New Point-of-Care System for HIV/AIDS Patients
Avellino Lab USA Launches New DNA Test for LASIK Safety
Sigma-Aldrich (NASDAQ - SIAL) Reports Record Q1 2014 Results With Sales Of $689 Million And Adjusted Diluted EPS Of $1.06. Reaffirms Full-Year 2014 Adjusted Diluted EPS Guidance Of $4.30 To $4.40.
Juno Completes $176M Series A Round
Oncothyreon Announces First Quarter 2014 Financial Results Conference Call English Portuguese
Sinovac Receives Notification of China Government Grant for EV71 Vaccine Project
Celsion Corporation Announces Updated Overall Survival Results from the HEAT Study of ThermoDox® in Primary Liver Cancer Presented at ECIO 2014
Phase 3 DECISION Trial of NEXAVAR (sorafenib) in Locally Recurrent or Metastatic, Progressive, Differentiated Thyroid Cancer Refractory to Radioactive Iodine Published in The Lancet
Array BioPharma To Report Financial Results For The Third Quarter Of Fiscal 2014 On April 29, 2014
SYLVANT™ (siltuximab) Receives FDA Approval to Treat Multicentric Castleman's Disease (MCD)
PTC Therapeutics to Present at Upcoming Investor Conferences
Acumed® introduces new Polarus® 3 Solution to treat proximal humerus fractures
CheckIssuing joins the Pharmaceutical Marketing Research Group
Lupin Appoints Theresa Stevens as Chief Corporate Development Officer
Binimetinib Continues To Advance In Clinical Development
Traveling Poses a Unique Set of Challenges for People with Blindness
Society for Clinical Research Sites Launches the Site Advocacy Group Initiative
Eravacycline's Improvements in Efficacy and Delivery Over Competitors will Drive Uptake for the Treatment of Gram-Negative Infections due to Multidrug-Resistant Enterobacteriaceae
Liventa Bioscience Responds To Lawsuit
MiMedx at SAWC Spring 2014: Multiple Studies And Clinical Experience Demonstrate Clinical And Cost Effectiveness Of EpiFix Allograft For Treatment Of Hard-to-Heal Wounds
PerceptiMed Founder Jacobs To Speak At Bio2Device Group Event
Lupin Inks Strategic Joint Venture Agreement with Yoshindo Inc.
Dotmatics Showcases Collaborative Project Tracking and Management Tool at Bio-IT World
WIRB-Copernicus Group's Chief Compliance Officer to Discuss Potential Impact of Corporate Consolidation on Human Research Protection Program Accreditation at 2014 AAHRPP Annual Conference
Generex Announces Antigen Express AE37 Breast Cancer Vaccine Abstract Presentations at ASCO 2014 Annual Meeting
Multi-Channel Pipettor QC Trends 2014 Market Research Report
AG Mednet Announces First Clinical Trial Quality Control Software for QIBA Imaging Protocol Compliance
Brandwidth Solutions Garners Four DxMA Creative Communications Awards for Clients
InterMune To Release First Quarter Financial Results On May 1
HemoShear Enters into R&D Collaboration with Medivir
Synthetic Biologics' Reports Preclinical Data to Support Clinical Development of Novel Pertussis Therapeutic
OncoGenex Announces Fast Track Designation Granted for Custirsen in Combination with Cabazitaxel/Prednisone as Second-line Chemotherapy in Phase 3 AFFINITY Trial of Men with Metastatic Castrate-Resistant Prostate Cancer
Surefire Medical's Groundbreaking COSY Clinical Trial Results Presented at ECIO: Is Coiling Prior to Radioembolization Still Necessary in Minimally Invasive Treatment of Liver Cancer?
PTC Therapeutics to Host Conference Call to Discuss First Quarter 2014 Financial Results
Luminex Corporation Announces Norovirus as a Launch Menu Assay for its New Sample-to-Answer System, ARIES™
Amgen's First Quarter 2014 Revenues Increased 7 Percent To $4.5 Billion
RXi Pharmaceuticals Enters into Financing Facility with Lincoln Park Capital
Southern Research Institute Develops Novel Screening Capability For Discovery Of Therapeutics To Address Highly Pathogenic Agents
Organogenesis to Present New Apligraf® and Dermagraft® Data at the Symposium on Advanced Wound Care and Wound Healing Society Annual Meeting
Octapharma Funds Observational Treatment Registry Study to Examine the Long Term Effects of Donor Specific Antibodies on Renal Transplant Recipients
Jonathan Hodgson Joins Putnam Associates as Principal

< Prev Next >
PR Newswire - United Business Media